The intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine.HCl, may potentiate doxorubicin in the treatment of metastatic breast cancer: Results of a pilot study

Author： Brandes Lorne   Bracken Susan  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.49, Iss.1, 1998-05, pp. : 61-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhancement of Antitumour Activity of Cisplatin by N,N-Diethyl-2-[4-(Phenylmethyl)Phenoxy] Ethanamine.HCl in Human Ovarian Cancer Cells with Intrinsic or Acquired Resistance to Cisplatin

By Kudoh K.   Kikuchi Y.   Hiramatsu H.   Hirata J.   Yamamoto K.   Kita T.   Nagata I.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 122-128

Elsevier

Access to resources Recommend Favorite

Combined Effects of Cisplatin and N, N-Diethyl-2-[4-(Phenylmethyl)Phenoxy] Ethanamine HCl on the Growth of Human Ovarian Cancer Xenografts in Nude Mice

By Hiramatsu H.   Kudoh K.   Kikuchi Y.   Hirata J.   Kita T.   Yamamoto K.   Tode T.   Nagata I.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1904-1905

Elsevier

Access to resources Recommend Favorite

Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 133-134

Informa Healthcare

Access to resources Recommend Favorite

Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study

By Alba Emilio   Ruiz-Borrego Manuel   Margelí Mireia   Rodríguez-Lescure Álvaro   Sánchez-Rovira Pedro   Ruiz Amparo   Mel-Lorenzo Jose   Ramos-Vázquez Manuel   Ribelles Nuria   Calvo Elisa   Casado Antonio   Márquez Antonia   Vicente David   García-Sáenz José   Martín Miguel  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 169-176

Springer Publishing Company

Access to resources Recommend Favorite

Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: Results from a multicenter prospective randomized trial

By Amadori D.   Frassineti G.L.   de Matteis A.   Mustacchi G.   Santoro A.   Cariello S.   Ferrari M.   Nascimben O.   Nanni O.   Lombardi A.   Scarpi E.   Zoli W.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 3, 1998-06 ,pp. : 209-217

Springer Publishing Company

Access to resources Recommend Favorite